Collegium Pharmaceutical, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US19459J1043
USD
47.43
-0.08 (-0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
188.00
177.76
181.95
159.30
145.28
144.92
149.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
188.00
177.76
181.95
159.30
145.28
144.92
149.75
Raw Material Cost
79.62
80.43
83.66
62.51
54.47
53.47
55.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.46
20.79
22.65
18.39
15.59
17.34
19.28
Selling and Distribution Expenses
72.70
73.74
58.65
42.07
43.34
41.98
32.94
Other Expenses
-2.05
-2.08
-2.27
-1.84
-1.56
-1.73
-1.93
Total Expenditure (Excl Depreciation)
152.32
154.17
142.31
104.58
97.81
95.45
88.06
Operating Profit (PBDIT) excl Other Income
35.699999999999996
23.599999999999998
39.6
54.699999999999996
47.5
49.5
61.7
Other Income
2.38
2.23
1.81
3.28
4.40
4.49
4.30
Operating Profit (PBDIT)
94.67
82.38
97.96
99.75
87.33
89.39
101.45
Interest
20.46
20.79
22.65
18.39
15.59
17.34
19.28
Exceptional Items
-0.58
-1.90
-1.53
-24.03
-7.18
0.00
0.00
Gross Profit (PBDT)
108.38
97.32
98.29
96.79
90.81
91.46
94.63
Depreciation
56.61
56.56
56.51
41.75
35.47
35.43
35.46
Profit Before Tax
17.02
3.12
17.27
15.58
29.10
36.62
46.71
Tax
5.04
0.70
4.73
6.25
9.49
8.91
14.77
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
11.98
2.42
12.54
9.34
19.61
27.71
31.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
11.98
2.42
12.54
9.34
19.61
27.71
31.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11.98
2.42
12.54
9.34
19.61
27.71
31.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
232.21
234.43
228.84
234.28
216.58
222.17
195.43
Earnings per share (EPS)
0.34
0.07
0.35
0.27
0.52
0.71
0.82
Diluted Earnings per share
0.34
0.07
0.35
0.27
0.52
0.71
0.82
Operating Profit Margin (Excl OI)
18.98%
13.27%
21.79%
34.35%
32.68%
34.14%
41.2%
Gross Profit Margin
39.17%
33.58%
40.55%
35.99%
44.44%
49.72%
54.88%
PAT Margin
6.37%
1.36%
6.89%
5.86%
13.5%
19.12%
21.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 5.74% vs -2.25% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 400.00% vs -80.80% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 15.09% vs -16.63% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -1.44% vs -8.37% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Collegium Pharmaceutical, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
188.00
103.74
84.26
81.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
188.00
103.74
84.26
81.22%
Raw Material Cost
79.62
20.62
59.00
286.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
20.46
4.66
15.80
339.06%
Selling and Distribution Expenses
72.70
26.38
46.32
175.59%
Other Expenses
-2.05
0.33
-2.38
-721.21%
Total Expenditure (Excl Depreciation)
152.32
54.99
97.33
177.00%
Operating Profit (PBDIT) excl Other Income
35.68
48.75
-13.07
-26.81%
Other Income
2.38
4.15
-1.77
-42.65%
Operating Profit (PBDIT)
94.67
62.93
31.74
50.44%
Interest
20.46
4.66
15.80
339.06%
Exceptional Items
-0.58
24.36
-24.94
-102.38%
Gross Profit (PBDT)
108.38
83.11
25.27
30.41%
Depreciation
56.61
10.04
46.57
463.84%
Profit Before Tax
17.02
72.60
-55.58
-76.56%
Tax
5.04
8.91
-3.87
-43.43%
Provisions and contingencies
0
0
0.00
Profit After Tax
11.98
63.69
-51.71
-81.19%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
11.98
63.69
-51.71
-81.19%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11.98
63.69
-51.71
-81.19%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
232.21
714.82
-482.61
-67.51%
Earnings per share (EPS)
0.34
0.77
-0.43
-55.84%
Diluted Earnings per share
0.34
0.77
-0.43
-55.84%
Operating Profit Margin (Excl OI)
18.98%
46.99%
0.00
-28.01%
Gross Profit Margin
39.17%
79.65%
0.00
-40.48%
PAT Margin
6.37%
61.39%
0.00
-55.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 18.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.74% vs -2.25% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 29.39% vs 7.23% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 400.00% vs -80.80% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -38.78% vs 50.77% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.23 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 15.09% vs -16.63% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.34% vs 12.18% in Jun 2024

Quarterly - Interest
Interest 2.05 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -1.44% vs -8.37% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 31.41% vs -28.77% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.98%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024